Compound: Ponatinib

Drug Target: ABL, PDGFRA, VEGFR2, FGFR1, SRC, TIE2, FLT3

Drug Target pathway: Other, kinases

Dataset


Tissue specific analysis

Statistics

All cell lines
Number of cell lines
Pearson correlation
Spearman correlation

Chart settings

Colour dots by:


Contact us | Cookies policy | Terms & Conditions. This site is hosted by the Wellcome Sanger Institute.